73.17
price up icon2.49%   1.78
after-market アフターアワーズ: 73.17
loading
前日終値:
$71.39
開ける:
$71.25
24時間の取引高:
1.69M
Relative Volume:
1.89
時価総額:
$11.63B
収益:
$1.17B
当期純損益:
$150.71M
株価収益率:
48.14
EPS:
1.52
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
-3.33%
1か月 パフォーマンス:
+6.48%
6か月 パフォーマンス:
-1.82%
1年 パフォーマンス:
-3.55%
1日の値動き範囲:
Value
$71.25
$74.27
1週間の範囲:
Value
$69.48
$77.62
52週間の値動き範囲:
Value
$61.16
$85.57

Bio Techne Corp Stock (TECH) Company Profile

Name
名前
Bio Techne Corp
Name
セクター
Healthcare (1176)
Name
電話
(612) 379-8854
Name
住所
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
職員
3,100
Name
Twitter
@biotechne
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
TECH's Discussions on Twitter

TECH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TECH
Bio Techne Corp
73.17 11.63B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-02-08 開始されました Scotiabank Sector Outperform
2024-02-02 ダウングレード Stifel Buy → Hold
2023-12-07 開始されました UBS Buy
2023-08-28 開始されました William Blair Outperform
2023-01-10 アップグレード Wells Fargo Underweight → Equal Weight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Sector Perform
2022-08-25 開始されました Credit Suisse Outperform
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2021-09-15 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 アップグレード Stephens Equal-Weight → Overweight
2021-02-23 アップグレード Stifel Hold → Buy
2021-01-25 繰り返されました The Benchmark Company Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-07-15 ダウングレード Stephens Overweight → Equal-Weight
2020-05-27 ダウングレード Stifel Buy → Hold
2020-05-14 開始されました The Benchmark Company Buy
2020-01-08 再開されました Stephens Overweight
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-11-15 開始されました Stifel Buy
2019-07-02 アップグレード Janney Neutral → Buy
2019-01-14 アップグレード Stephens Equal-Weight → Overweight
2018-10-31 ダウングレード Craig Hallum Buy → Hold
2018-10-17 開始されました Goldman Neutral
2018-06-15 開始されました Argus Buy
2017-07-13 開始されました Wells Fargo Market Perform
2017-02-09 開始されました Citigroup Buy
2017-01-18 開始されました Deutsche Bank Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-01-21 繰り返されました Robert W. Baird Outperform
2013-09-20 アップグレード Robert W. Baird Neutral → Outperform
すべてを表示

Bio Techne Corp (TECH) 最新ニュース

pulisher
Dec 20, 2024

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Yahoo Finance

Dec 20, 2024
pulisher
Dec 19, 2024

Bio-Techne Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Dec 19, 2024
pulisher
Dec 19, 2024

Bio-Techne partners with Waters for biotherapeutic tech - Investing.com

Dec 19, 2024
pulisher
Dec 19, 2024

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT - Yahoo Finance

Dec 19, 2024
pulisher
Dec 18, 2024

ScaleReady awards a G-Rex® Grant to Moonlight Bio - Yahoo Finance

Dec 18, 2024
pulisher
Dec 16, 2024

Lord Abbett & CO. LLC Has $23.73 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Bio-Techne Co. (NASDAQ:TECH) Short Interest Up 15.6% in November - MarketBeat

Dec 15, 2024
pulisher
Dec 15, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Toronto Dominion Bank - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Oddo BHF Asset Management Sas Invests $1.19 Million in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 14, 2024
pulisher
Dec 14, 2024

Barclays PLC Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 14, 2024
pulisher
Dec 13, 2024

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain? - MSN

Dec 13, 2024
pulisher
Dec 13, 2024

National Bank of Canada FI Purchases 37,181 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 13, 2024
pulisher
Dec 12, 2024

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY - Quantisnow

Dec 12, 2024
pulisher
Dec 11, 2024

S&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, Bio-Techne Lag - Barron's

Dec 11, 2024
pulisher
Dec 10, 2024

West Sac-based GeminiBio acquires a large serum producer's brands, customers - The Business Journals

Dec 10, 2024
pulisher
Dec 10, 2024

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - Yahoo Finance

Dec 10, 2024
pulisher
Dec 10, 2024

Wellington Management Group LLP Sells 147,797 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 10, 2024
pulisher
Dec 09, 2024

State Street Corp Grows Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 09, 2024
pulisher
Dec 08, 2024

Tenere Capital LLC Grows Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Worldquant Millennium Advisors LLC Buys 22,185 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 08, 2024
pulisher
Dec 06, 2024

Polar Asset Management Partners Inc. Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Janus Henderson Group PLC Lowers Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Can Mixed Financials Have A Negative Impact on Bio-Techne Corporation's 's (NASDAQ:TECH) Current Price Momentum? - Yahoo Finance

Dec 04, 2024
pulisher
Dec 04, 2024

PEAK6 Investments LLC Invests $698,000 in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance

Dec 03, 2024
pulisher
Dec 03, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Why Bio-Techne Corp (TECH) Is Set to Outperform the Market: Insi - GuruFocus.com

Dec 02, 2024
pulisher
Dec 02, 2024

Bamco Inc. NY Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

Should You Continue to Retain Bio-Techne Stock in Your Portfolio? - Yahoo Finance

Dec 02, 2024
pulisher
Dec 02, 2024

BNP Paribas Financial Markets Sells 52,235 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 02, 2024
pulisher
Dec 02, 2024

The Manufacturers Life Insurance Company Has $15.93 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 02, 2024
pulisher
Dec 01, 2024

American Capital Management Inc. Has $89.07 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

Fred Alger Management LLC Has $52.07 Million Stake in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 30, 2024
pulisher
Nov 30, 2024

Analysts Set Bio-Techne Co. (NASDAQ:TECH) Price Target at $81.78 - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

TECH (Bio-Techne) 3-Year Revenue Growth Rate : 7.80% (As of Sep. 2024) - GuruFocus.com

Nov 29, 2024
pulisher
Nov 29, 2024

Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Nov 29, 2024
pulisher
Nov 29, 2024

Dai ichi Life Insurance Company Ltd Has $423,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Gene Editing Market Forecast Report 2024, with Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More - Yahoo Finance

Nov 29, 2024
pulisher
Nov 27, 2024

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE - Quantisnow

Nov 27, 2024
pulisher
Nov 27, 2024

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE – Company Announcement - Financial Times

Nov 27, 2024
pulisher
Nov 26, 2024

Charles Schwab Investment Management Inc. Has $113.02 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 26, 2024
pulisher
Nov 26, 2024

Bio-Techne Co. (NASDAQ:TECH) Position Raised by Cerity Partners LLC - MarketBeat

Nov 26, 2024
pulisher
Nov 25, 2024

Bio-Techne (TECH) Shares Cross Above 200 DMA - Nasdaq

Nov 25, 2024
pulisher
Nov 23, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Eagle Asset Management Inc. - MarketBeat

Nov 23, 2024
pulisher
Nov 23, 2024

Massachusetts Financial Services Co. MA Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 23, 2024
pulisher
Nov 23, 2024

Mutual of America Capital Management LLC Purchases 8,852 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 23, 2024
pulisher
Nov 22, 2024

Bio-Techne (MEX:TECH) Dividend Payout Ratio : 0.19 (As of Sep. 2024) - GuruFocus.com

Nov 22, 2024
pulisher
Nov 21, 2024

Bio-Techne (MEX:TECH) Debt-to-Equity : 0.19 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart

Nov 21, 2024
pulisher
Nov 21, 2024

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb or Sink? - Inkl

Nov 21, 2024
pulisher
Nov 21, 2024

Bio-Techne (BSP:T1CH34) Enterprise Value : R$70,339 Mil (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024

Bio Techne Corp (TECH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Bio Techne Corp (TECH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Hippel James
CFO
Nov 01 '24
Option Exercise
0.00
13,159
0
113,085
HIGGINS JOHN L
Director
Sep 12 '24
Option Exercise
22.95
6,000
137,700
48,608
Kelderman Kim
Chief Executive Officer
Aug 29 '24
Option Exercise
66.97
1,492
99,919
41,434
Bohnen Shane
SVP - General Counsel
Aug 15 '24
Option Exercise
0.00
49
0
1,696
BAUMGARTNER ROBERT V
Director
Aug 08 '24
Option Exercise
22.95
16,000
367,200
59,401
BAUMGARTNER ROBERT V
Director
Aug 08 '24
Sale
72.10
16,000
1,153,664
43,401
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):